Sort
30,917 grants matching “tumor microenvironment”
Low-Fat/Fish Oil Diet and prostate Cancer Outcomes in Human Cohorts and Mouse Mo
$256,935William J Aronson · University Of California Los Angeles · P50 · FY2017 · CA
Project 1: Modeling the Interface between Non-invasive Imaging and Drug Distribution
$256,932Kristin R Swanson · Massachusetts Institute Of Technology · U54 · FY2019 · CA
Improving T Cell Therapies for Nasopharyngeal Cancer
$256,879Helen E Heslop · Baylor College Of Medicine · P01 · FY2014 · CA
Molecular mechanism of cell invasion
$256,863Wen-Tien Chen · State University New York Stony Brook · R01 · FY2007 · CA
Mesenchymal Derived Growth Factors in Prostatic Cancer
$256,863David R Rowley · Baylor College Of Medicine · R01 · FY2008 · CA
Mesenchymal Derived Growth Factors in Prostatic Cancer
$256,863David R Rowley · Baylor College Of Medicine · R01 · FY2007 · CA
Core 1: Mouse Model and Tissue Biobank Core
$256,772Roger S Lo · Institute For Systems Biology · U54 · FY2024 · CA
Development of Molecularly Targeted Imaging Agents for Early Detection of PDAC
$256,669Kimberly A. Kelly · University Of Virginia · R01 · FY2009 · CA
Cognitive Behavioral Effects on Sleep, Pain, and Cytokines in Gynecologic Cancer
$256,662Deidre B Pereira · University Of Florida · R01 · FY2013 · CA
Role of Missing Metastasis Gene in tumor progression
$256,625Steven Zhan · University Of Maryland Baltimore · R01 · FY2014 · CA
Altering Post Vaccination T Cell Contraction
$256,624David J Cole · Medical University Of South Carolina · R01 · FY2006 · CA
CEST MRI Agents for Receptor Imaging
$256,587Michael T McMahon · Johns Hopkins University · P41 · FY2021 · EB
Tumor oxygenation, vascularization, and radioresponse
$256,584Bruce M Fenton · University Of Rochester · R01 · FY2006 · CA
Integrative Functional Profiling of Tumor-Derived Extracellular Vesicles
$256,562Yong Zeng · University Of Florida · R33 · FY2024 · CA
Evolution and targeting of the functional states of glioblastoma
$256,507Anna Lasorella · Columbia University Health Sciences · R01 · FY2022 · CA
The impact of mucociliary clearance on Mycobacterium tuberculosis pathogenesis
$256,475Javeed Ali Shah · University Of Washington · R21 · FY2023 · AI
IKK<alpha> and the control of prostate cancer metastasis
$256,269Michael Karin · University Of California, San Diego · R01 · FY2011 · CA
Development of Molecularly Targeted Imaging Agents for Early Detection of PDAC
$256,194Kimberly A. Kelly · University Of Virginia · R01 · FY2010 · CA
VSV INFECTION OF THE CENTRAL NERVOUS SYSTEM
$256,184New York University · R01 · FY2001 · DC
Leveraging doxorubicin immune-modulation, blood-brain barrier opening, and personalized medicine for effective immunotherapy in glioblastoma. A mechanistic approach and pharmacokinetic trial.
$256,156Adam M Sonabend · University Of California, San Francisco · U19 · FY2024 · CA
Project 3: Inter-Relationships and Prognostic Significance of Breast Cancer Radiomic Risk Features, Tissue Microenvironment, and Adiposity
$256,152John Alan Shepherd · University Of Hawaii At Manoa · P20 · FY2024 · CA
DC AML Fusion Cell Vaccination with Immune checkpoint Blockade
$256,093Gordon James Freeman · Brigham And Women'S Hospital · P50 · FY2017 · CA
EphA2 kinase in prostate cancer
$256,089Bingcheng Wang · Case Western Reserve University · R01 · FY2016 · CA
In situ anti-tumor immunity and effects of radiation
$256,025Edith M. Lord · University Of Rochester · R01 · FY2020 · CA
In situ anti-tumor immunity and effects of radiation
$256,025Edith M. Lord · University Of Rochester · R01 · FY2018 · CA